Author Correction to: Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson’s Disease

Lawrence W. Elmer, Jorge L. Juncos, Carlos Singer, Daniel D. Truong, Susan R. Criswell, Sotirios Parashos, Larissa Felt, Reed Johnson, Rajiv Patni

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

An Online First version of this article was made available online at http://link.springer.com/journal/40263/onlineFirst/page/1on 12 March 2018. An error was subsequently identified in the article, and the following correction should be noted.

Original languageEnglish (US)
Pages (from-to)1-2
Number of pages2
JournalCNS Drugs
DOIs
StateAccepted/In press - Apr 10 2018

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Author Correction to: Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson’s Disease'. Together they form a unique fingerprint.

  • Cite this